Showing results (491-500 of 5,340) with videos related to
Sort By:
Pageof 534
Japanese Journal of Clinical Oncology|July 31, 2019
Safety and efficacy of cabazitaxel in 660 patients with metastatic castration-resistant prostate cancer in real-world settings: results of a Japanese post-marketing surveillance studyKazuhiro Suzuki, Nobuaki Matsubara, Hirotaka Kazama, et al.Japanese Journal of Clinical Oncology|April 15, 2014
Negative human papillomavirus status and excessive alcohol consumption are significant risk factors for second primary malignancies in Japanese patients with oropharyngeal carcinomaYuki Saito, Yasuhiro Ebihara, Tetsuo Ushiku, et al.Japanese Journal of Clinical Oncology|April 15, 2014
Japanese structure survey of high-precision radiotherapy in 2012 based on institutional questionnaire about the patterns of careNatsuo Tomita, Takeshi Kodaira, Teruki Teshima, et al.Japanese Journal of Clinical Oncology|April 24, 2014
Cancer incidence trends in IndiaRajendra A Badwe, Rajesh Dikshit, M Laversanne, et al.Japanese Journal of Clinical Oncology|July 23, 2019
Mesenchymal-epithelial transition gene amplification and protein overexpression in stage IV pulmonary adenocarcinomaRyota Ando, Masahiko Fujino, Ayami Kominami-Kiriyama, et al.Japanese Journal of Clinical Oncology|November 15, 2018
A primary analysis of a multicenter, prospective, single-arm, confirmatory trial of hypofractionated whole breast irradiation after breast-conserving surgery in Japan: JCOG0906Miwako Nozaki, Yoshikazu Kagami, Taro Shibata, et al.Japanese Journal of Clinical Oncology|April 19, 2017
Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup analysis from the CheckMate 025 studyYoshihiko Tomita, Satoshi Fukasawa, Nobuo Shinohara, et al.Japanese Journal of Clinical Oncology|April 19, 2017
Accessibility to surgical robot technology and prostate-cancer patient behavior for prostatectomyToru Sugihara, Hideo Yasunaga, Hiroki Matsui, et al.Japanese Journal of Clinical Oncology|April 19, 2017
Efficacy and safety of osimertinib in a Japanese compassionate use programYutaka Fujiwara, Yasushi Goto, Shintaro Kanda, et al.Japanese Journal of Clinical Oncology|September 1, 1988
The efficacy of high-dose 4'epidoxorubicin in hepatocellular carcinomaW Shiu, N Leung, M Li, et al.Pageof 534